Jeremy Farrar

Last updated

Sir Jeremy Farrar
OBE FRS FRCP FMedSci
Jeremy Farrar, Chief Scientist, World Health Organization 7 (cropped).jpg
Farrar at 2024 Nobel Week
Born
Jeremy James Farrar

(1961-09-01) 1 September 1961 (age 63) [1]
Singapore
NationalityBritish
Education Churcher's College
Alma mater
Spouse
Christiane Dolecek
​
(m. 1998)​
Awards Order of Ho Chi Minh [3]
Scientific career
Fields
Institutions
Thesis Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient  (1997)
Website

Sir Jeremy James Farrar (born 1 September 1961) [1] is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. [8] He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford. [1] [7] [9] [10] [11] [12]

Contents

Early life and education

Born in Singapore, Farrar is the youngest of six children in his family. His father taught English and his mother was a writer and artist. Due to his father's work, he spent his childhood in New Zealand, Cyprus and Libya. [13]

Farrar was educated at Churcher's College [14] and UCL Medical School, [15] from where he obtained a Bachelor of Science degree in immunology in 1983 and a Bachelor of Medicine, Bachelor of Surgery degree in 1986. [2] Farrar completed his Doctor of Philosophy degree at the University of Oxford in 1998 on myasthenia gravis. [16]

Career and research

Farrar's research interests are in infectious diseases [15] such as tuberculosis, [17] dengue fever, [18] [19] [20] [21] typhoid fever, malaria, and H5N1 influenza. [4] [22] [23] [24]

Career in academia

From 1996 until 2013, Farrar was Director of the Oxford University Clinical Research Unit in Ho Chi Minh City. [5] [25] [26] [27] In 2004, he and his Vietnamese colleague Tran Tinh Hien identified the re-emergence of the deadly bird flu, or H5N1, in humans. [28] [29] He was Professor of Tropical Medicine and Global Health at the University of Oxford from 2000 until 2013. [1]

In addition to his academic work, Farrar was part of the Center for Global Development’s Working Group on Priority-Setting Institutions for Global Health in 2012. [30]

Wellcome Trust, 2013–2023

In 2013, Farrar was appointed Director of the Wellcome Trust. [1] During his time at the Wellcome Trust, with Chris Whitty and Neil Ferguson, he co-authored an article in Nature titled "Infectious disease: Tough choices to reduce Ebola transmission", [31] explaining the UK government's response to Ebola in Sierra Leone, including the proposal to build and support centres where people could self-isolate voluntarily if they suspected that they could have the disease. [32] In July 2015, he co-authored a paper in The New England Journal of Medicine (with Adel Mahmoud and Stanley A. Plotkin), titled "Establishing a Global Vaccine-Development Fund", that led to the founding in 2017 of the Coalition for Epidemic Preparedness Innovations (CEPI). [33] [34] Together with a number of others, in 2016 he proposed a World Serum Bank as a means of helping combat epidemics. [35]

In addition to his role at the Wellcome Trust, Farrar has served as chair on several advisory boards for governments and global organizations. In 2017, he was part of the selection committee chaired by Jules A. Hoffmann that chose Stewart Cole as director of the Institut Pasteur. [36] From 2017 until 2019, he was a member of the German Ministry of Health’s International Advisory Board on Global Health, chaired by Ilona Kickbusch. [37] In 2019 he served on The Lancet Commission on Tuberculosis, co-chaired by Eric Goosby, Dean Jamison and Soumya Swaminathan. [38] He is also a member of the Health and Biomedical Sciences International Advisory Council (HBMS IAC) at the Agency for Science, Technology and Research of Singapore. [39]

In 2020, he was appointed to the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley. [40] In the preparations for the Global Health Summit hosted by the European Commission and the G20 in May 2021, he was a member of the event's High Level Scientific Panel. [41]

Farrar has served on a number of WHO committees, co-chairing the World Health Organization’s working group on dengue vaccines from 2015 until 2016. [42] [43] Since its inception in 2017, Farrar has been chairing the Scientific Advisory Group of the WHO R&D Blueprint, a global strategy and preparedness plan that allows the rapid activation of research activities during epidemics. [44] From 2018 to 2022, he served on the joint World Bank/WHO Global Preparedness Monitoring Board (GPMB), co-chaired by Elhadj As Sy and Gro Harlem Brundtland. [45] [46] In 2019, he co-chaired a WHO committee evaluating Ebola therapeutics. [47] [48]

Farrah has also served on UK governments committees. In May 2020, amid the COVID-19 pandemic, he was appointed to the expert advisory group for the UK Government’s Vaccine Task Force. [49] He has also served as a member of the UK Scientific Advisory Group for Emergencies (SAGE), led by Patrick Vallance [50] (up to 2 November 2021, when Farrar resigned in disagreement with the government's approach), and Public Health England’s Serology Working Group. [51] During Farrar's time in SAGE, Health Secretary Matt Hancock sought to have him removed from the group following his criticisms of the government's handling of Covid, the abolition of Public Health England (PHE) and the appointment of Dido Harding to head the ineffective and expensive Test and Trace programme. [52]

[49] In July 2021 he published the book Spike: The Virus vs The People, co-authored with Financial Times journalist Anjana Ahuja, giving his account of the UK government's response to the Covid-19 pandemic. [53]

Farrar was listed in Time's 2024 most influential people in health list. [54]

Views

On 19 February 2020, Farrar, along with 26 other scientists, published as a co-author of the Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19, which declared "We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin."

Farrar wrote an opinion piece in the Guardian on Dec. 4, 2021 stating he feared not enough was being done to vaccinate people in poor nations against COVID-19. Farrar stated, “The longer this virus continues to spread in largely unvaccinated populations globally, the more likely it is that a variant that can overcome our vaccines and treatments will emerge. If that happens, we could be close to square one. This political drift and lack of leadership is prolonging the pandemic for everyone, with governments unwilling to really address inequitable access to the vaccines, tests and treatment. There have been wonderful speeches, warm words, but not the actions needed to ensure fair access to what we know works and would bring the pandemic to a close.” [55]

Other activities

Corporate boards

Non-profit organizations

Awards and honours

Farrar is a member of the Royal College of Physicians and a Fellow of the Academy of Medical Sciences. He was appointed Officer of the Order of the British Empire in the 2005 New Year Honours for services to healthcare, especially the prevention of tropical diseases, in Vietnam. [76] His citation on election to the Academy of Medical Sciences reads: [77]

Jeremy Farrar is director of the Wellcome Trust-funded Oxford University Clinical Research Unit. Over the past ten years he has created a remarkable research institute in which his own research productivity has been phenomenal and an impressive training program has been developed. Under his direction the research programme has conducted seminal work on malaria, dengue, typhoid, tetanus, pyogenic and tuberculous meningitis and has become the leading centre for clinical research on avian influenza. These Pivotal clinical and virological studies have identified the dual importance of viral burden and the cytokine response to the lethal pathogenesis of avian influenza, and have described the rapid emergence of resistance to neuraminidase inhibitors. The unit has also conducted important research into Dengue shock syndrome, conducting the only large prospective randomised trials of fluid replacement and has provided an evidence-base for revision of the World Health Organisation classification. His commitment to fighting emerging infectious diseases at their source in developing countries is commendable and his contribution to capacity building in Vietnam and other countries is vital for the future of health care in these regions and serves as a model for others to follow.

Farrar was elected a Fellow of the Royal Society in 2015. [78] He was appointed a Knight Bachelor in the 2019 New Year Honours for services to Global Health. [79]

Personal life

Farrar has been married to Christiane Dolecek, an Austrian-born typhoid researcher, since 1998. [28] They have three children and live in Oxford. [28] Since 2011, the family [80] has focused on providing educational assistance to youth from Vietnam and Nepal. [81]

Related Research Articles

<span class="mw-page-title-main">Dengue fever</span> Mosquito-borne disease

Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic; if symptoms appear they typically begin 3 to 14 days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin itching and skin rash. Recovery generally takes two to seven days. In a small proportion of cases, the disease develops into severe dengue with bleeding, low levels of blood platelets, blood plasma leakage, and dangerously low blood pressure.

<span class="mw-page-title-main">Arbovirus</span> Class of viruses which are transmitted by arthropods

Arbovirus is an informal name for any virus that is transmitted by arthropod vectors. The term arbovirus is a portmanteau word. Tibovirus is sometimes used to more specifically describe viruses transmitted by ticks, a superorder within the arthropods. Arboviruses can affect both animals and plants. In humans, symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last three or four days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and viral hemorrhagic fever may also occur.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot is a Belgian-British microbiologist known for his research into Ebola and AIDS.

<span class="mw-page-title-main">Transmission and infection of H5N1</span> Spread of an influenza virus

Transmission and infection of H5N1 from infected avian sources to humans has been a concern since the first documented case of human infection in 1997, due to the global spread of H5N1 that constitutes a pandemic threat.

Sir Roy Malcolm Anderson is a leading international authority on the epidemiology and control of infectious diseases. He is the author, with Robert May, of the most highly cited book in this field, entitled Infectious Diseases of Humans: Dynamics and Control. His early work was on the population ecology of infectious agents before focusing on the epidemiology and control of human infections. His published research includes studies of the major viral, bacterial and parasitic infections of humans, wildlife and livestock. This has included major studies on HIV, SARS, foot and mouth disease, bovine tuberculosis, bovine spongiform encephalopathy (BSE), influenza A, antibiotic resistant bacteria, the neglected tropical diseases and most recently COVID-19. Anderson is the author of over 650 peer-reviewed scientific articles with an h-index of 125.

The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Dr. Michael Osterholm, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions". It is not part of the Center for Disease Control or National Institute of Health.

Thomas Solomon is Professor of Neurology at the University of Liverpool, director of The Pandemic Institute and director of the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections. He is also vice president (international) of the Academy of Medical Sciences. and Academic Vice President at the Royal College of Physicians.

<span class="mw-page-title-main">Ebola vaccine</span> Vaccine against Ebola

Ebola vaccines are vaccines either approved or in development to prevent Ebola. As of 2022, there are only vaccines against the Zaire ebolavirus. The first vaccine to be approved in the United States was rVSV-ZEBOV in December 2019. It had been used extensively in the Kivu Ebola epidemic under a compassionate use protocol. During the early 21st century, several vaccine candidates displayed efficacy to protect nonhuman primates against lethal infection.

<span class="mw-page-title-main">Coalition for Epidemic Preparedness Innovations</span> Public-private organization for vaccine development

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

<span class="mw-page-title-main">John P. Woodall</span> American entomologist

John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.

<span class="mw-page-title-main">Nelson Michael</span> American infectious disease researcher

Nelson L. Michael is an American infectious disease researcher. He has served for nearly 30 years in the United States Army and been directly involved with significant advancements in understanding the pathology of and vaccine development for diseases like HIV, Zika, Ebola and more. Much of his career has been spent at the Walter Reed Army Institute of Research.

Dr. Daniel R. Lucey is an American physician, researcher, clinical professor of medicine of infectious diseases at Geisel School of Medicine at Dartmouth, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

Peter Salama was an Australian epidemiologist who worked for UNICEF (2002–16) and the World Health Organization (2016–19). He was particularly known for his work at both organisations managing their responses to Ebola epidemics in Africa. Richard Horton, editor of The Lancet, described him as "a loyal and committed health advocate and multilateralist" who "brought depth and strength to WHO".

<span class="mw-page-title-main">Neil Ferguson (epidemiologist)</span> British epidemiologist and researcher

Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.

<span class="mw-page-title-main">Michael J. Ryan (doctor)</span> Irish doctor and Chief Executive Director of the WHO Health Emergencies Programme

Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.

<span class="mw-page-title-main">Peter Daszak</span> British zoologist

Peter Daszak is a British zoologist, consultant and public expert on disease ecology, in particular on zoonosis. He is the president of EcoHealth Alliance, a nonprofit non-governmental organization that supports various programs on global health and pandemic prevention. He is also a member of the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. He lives in Suffern, New York.

A human challenge study, also called a challenge trial or controlled human infection model (CHIM), is a type of clinical trial for a vaccine or other pharmaceutical involving the intentional exposure of the test subject to the condition tested. Human challenge studies may be ethically controversial because they involve exposing test subjects to dangers beyond those posed by potential side effects of the substance being tested. Controlled human infection studies are also used to study viruses and immune responses.

The Strategic Advisory Group of Experts (SAGE) is the principal advisory group to World Health Organization (WHO) for vaccines and immunization. Established in 1999 through the merging of two previous committees, notably the Scientific Advisory Group of Experts and the Global Advisory Group by Director-General of the WHO Gro Harlem Brundtland. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and biotechnology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases. SAGE provide global recommendations on immunization policy and such recommendations will be further translated by advisory committee at the country level.

<span class="mw-page-title-main">Scott Halstead</span> American scientist and virologist

Scott Halstead is an American physician-scientist, virologist and epidemiologist known for his work in the fields of tropical medicine and vaccine development. He is considered one of the world's foremost authorities on viruses transmitted by mosquitoes, including Dengue, Japanese encephalitis, chikungunya and Zika. He was one of the first researchers to identify the phenomenon known as antibody-dependent enhancement (ADE), where the antibodies generated from a first dengue infection can sometimes worsen the symptoms from a second infection.

Sanjeev Krishna,, is a British physician and parasitologist whose research focuses on affordable diagnosis and treatment of diseases such as COVID-19, malaria, Ebola, African trypanosomiasis, leishmaniasis, and colorectal cancer. Krishna is Professor of Medicine and Molecular Parasitology at St George's, University of London and St George's Hospital.

References

  1. 1 2 3 4 5 Anon (2016). "Farrar, Sir Jeremy (James)" . Who's Who (online Oxford University Press  ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.U275899.(Subscription or UK public library membership required.)
  2. 1 2 "Jeremy Farrar". antimicrobe.org.
  3. ↑ "Jeremy Farrar – Epidemiologist". BBC.
  4. 1 2 Woolhouse, Mark; Farrar, Jeremy (2014). "Policy: An intergovernmental panel on antimicrobial resistance". Nature. 509 (7502): 555–7. doi: 10.1038/509555a . PMID   24877180.
  5. 1 2 "Oxford University Clinical Research Unit". oucru.org.
  6. ↑ The Farrar Foundation, farrarfoundation.org
  7. 1 2 Farrar, J; Cressey, D (2014). "Straight talk with...Jeremy Farrar". Nature Medicine. 20 (2): 112. doi: 10.1038/nm0214-112 . PMID   24504397. S2CID   205376332.
  8. ↑ Anon (2022). "World Health Organization names Sir Jeremy Farrar as Chief Scientist, Dr Amelia Latu Afuhaamango Tuipulotu as Chief Nursing Officer". who.int.
  9. ↑ Van Noorden, Richard (2013). "Clinician to head Wellcome Trust: Jeremy Farrar to lead one of world's largest research charities". Nature. 497 (7447): 19. Bibcode:2013Natur.497...19V. doi: 10.1038/497019a . PMID   23636375.
  10. ↑ Maxmen, A. (2009). "Jeremy Farrar: When disaster strikes". Journal of Experimental Medicine. 206 (1): 4–5. doi:10.1084/jem.2061pi. PMC   2626674 . PMID   19153250.
  11. ↑ Jeremy Farrar publications indexed by the Scopus bibliographic database. (subscription required)
  12. ↑ A very Wellcome appointment: Professor Jeremy Farrar, who takes over as director of the Wellcome Trust in October 2013, The Guardian, 25 April 2013
  13. ↑ James Ashton (18 January 2015), Jeremy Farrar interview: Wellcome Trust director says 'I'm not a great believer in the power of prayer' The Independent .
  14. ↑ Iqbal, Nosheen (6 December 2020). "Covid scientist Jeremy Farrar had recurring nightmare about failing A-levels". The Guardian.
  15. 1 2 Jeremy Farrar Interviewed by Jim Al-Khalili on The Life Scientific, 14 July 2014
  16. ↑ Farrar, Jeremy (1997). Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient (DPhil thesis). University of Oxford. EThOS   uk.bl.ethos.339366.
  17. ↑ Thwaites, G. E.; Nguyen, N. D.; Nguyen, N. H.; Hoang, H. T.; Do, D. T. T.; Nguyen, N. T. C.; Nguyen, N. Q.; Nguyen, N. T.; Nguyen, N. N.; Nguyen, N. T. N.; Nguyen, N. N.; Nguyen, N. H.; Vu, V. N.; Cao, C. H.; Tran, T. T. H.; Pham, P. P.; Nguyen, N. T.; Stepniewska, K.; White, N. J.; Tran, T. T.; Farrar, J. J. (2004). "Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults". New England Journal of Medicine. 351 (17): 1741–1751. doi: 10.1056/NEJMoa040573 . PMID   15496623.
  18. ↑ Tricou, V.; Vu, H. T.; Quynh, N. V.; Nguyen, C. V.; Tran, H. T.; Farrar, J.; Wills, B.; Simmons, C. P. (2010). "Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses". BMC Infectious Diseases. 10: 142. doi: 10.1186/1471-2334-10-142 . PMC   2895602 . PMID   20509940.
  19. ↑ Guzman, M. G.; Halstead, S. B.; Artsob, H.; Buchy, P.; Farrar, J.; Gubler, D. J.; Hunsperger, E.; Kroeger, A.; Margolis, H. S.; Martínez, E.; Nathan, M. B.; Pelegrino, J. L.; Simmons, C.; Yoksan, S.; Peeling, R. W. (2010). "Dengue: A continuing global threat". Nature Reviews Microbiology. 8 (12): S7–16. doi:10.1038/nrmicro2460. PMC   4333201 . PMID   21079655.
  20. ↑ Wills, B. A.; Dung, N. M.; Loan, H. T.; Tam, D. T. H.; Thuy, T. T. N.; Minh, L. T. T.; Diet, T. V.; Hao, N. T.; Chau, N. V.; Stepniewska, K.; White, N. J.; Farrar, J. J. (2005). "Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome". New England Journal of Medicine. 353 (9): 877–89. doi: 10.1056/NEJMoa044057 . PMID   16135832. S2CID   30791461.
  21. ↑ Solomon, T.; Dung, N. M.; Vaughn, D. W.; Kneen, R.; Thao, L. T. T.; Raengsakulrach, B.; Loan, H. T.; Day, N. P.; Farrar, J.; Myint, K. S.; Warrell, M. J.; James, W. S.; Nisalak, A.; White, N. J. (2000). "Neurological manifestations of dengue infection". The Lancet. 355 (9209): 1053–1059. doi:10.1016/S0140-6736(00)02036-5. PMID   10744091. S2CID   21731410.
  22. ↑ Farrar, J. (2012). "H5N1 surveillance: Shift expertise to where it matters". Nature. 483 (7391): 534–535. Bibcode:2012Natur.483..534F. doi: 10.1038/483534a . PMC   7095293 . PMID   22460881.
  23. ↑ Hien, T. T.; Nguyen, N. T.; Nguyen, N. T.; Luong, L. T.; Pham, P. P.; Nguyen, N. V. V.; Pham, P. T.; Vo, V. C.; Le, L. T. Q.; Ngo, N. T.; Dao, D. B.; Le, L. P.; Nguyen, N. T.; Hoang, H. T.; Cao, C. V.; Le, L. T.; Nguyen, N. D.; Le, L. H.; Nguyen, N. T. K.; Le, L. H.; Le, L. V.; Christiane, C.; Tran, T. T.; Menno De, M.; Schultsz, C.; Cheng, P.; Lim, W.; Horby, P.; Farrar, J.; World Health Organization International Avian Influenza Investigative Team (2004). "Avian Influenza A (H5N1) in 10 Patients in Vietnam". New England Journal of Medicine. 350 (12): 1179–1188. doi: 10.1056/NEJMoa040419 . PMID   14985470.
  24. ↑ De Jong, M. D.; Simmons, C. P.; Thanh, T. T.; Hien, V. M.; Smith, G. J. D.; Chau, T. N. B.; Hoang, D. M.; Chau, N.; Khanh, T. H.; Dong, V. C.; Qui, P. T.; Cam, B.; Ha Do, D. Q.; Guan, Y.; Peiris, J. S. M.; Chinh, N. T.; Hien, T. T.; Farrar, J. (2006). "Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia". Nature Medicine. 12 (10): 1203–1207. doi:10.1038/nm1477. PMC   4333202 . PMID   16964257.
  25. ↑ Watts, Geoff (2013). "Jeremy Farrar: Wellcome arrival from southeast Asia". The Lancet. 382 (9899): 1167. doi:10.1016/S0140-6736(13)62047-4. PMID   24095187. S2CID   205970840.
  26. ↑ Jeremy Farrar on Connecting your research with society on YouTube
  27. ↑ Exchanges at the Frontier: Jeremy Farrar on YouTube
  28. 1 2 3 Annie Maccoby Berglof (20 June 2014), At Home with the FT House & Home: Wellcome Trust director Jeremy Farrar Financial Times .
  29. ↑ Jeremy Farrar seeks innovative backgrounds to help fight infectious diseases, Wired UK on YouTube
  30. ↑ Working Group on Priority-Setting Institutions for Global Health Center for Global Development (CGD).
  31. ↑ Whitty, Christopher J. M.; Farrar, Jeremy; Ferguson, Neil; Edmunds, W. John; Piot, Peter; Leach, Melissa; Davies, Sally C. (2014). "Infectious disease: Tough choices to reduce Ebola transmission". Nature. 515 (7526): 192–194. Bibcode:2014Natur.515..192W. doi: 10.1038/515192a . PMID   25391946.
  32. ↑ "Infectious disease: Tough choices to reduce Ebola transmission | Ebola Response Anthropology Platform". www.ebola-anthropology.net. Retrieved 10 March 2020.
  33. 1 2 Jon Cohen (2 September 2016). "New vaccine coalition aims to ward off epidemics". Science. 353 (6303).
  34. ↑ Stanley A. Plotkin; Adel A.F. Mahmoud; Jeremy Farrar (23 July 2015). "Establishing a Global Vaccine-Development Fund". The New England Journal of Medicine . 373 (4): 297–300. doi: 10.1056/NEJMp1506820 . PMID   26200974.
  35. ↑ Metcalf, C Jessica E.; Farrar, Jeremy; Cutts, Felicity T.; Basta, Nicole E.; Graham, Andrea L.; Lessler, Justin; Ferguson, Neil M.; Burke, Donald S.; Grenfell, Bryan T. (2016). "Use of serological surveys to generate key insights into the changing global landscape of infectious disease". The Lancet. 388 (10045): 728–730. doi:10.1016/S0140-6736(16)30164-7. PMC   5678936 . PMID   27059886.
  36. ↑ Launch of the recruitment process for the Director of the Institut Pasteur Institut Pasteur, press release of 2 May 2017.
  37. ↑ Four new members complete the International Advisory Board on Global Health Federal Ministry of Health, press release of July 2, 2018.
  38. ↑ Commissioners The Lancet Commission on TB.
  39. ↑ Health and Biomedical Sciences International Advisory Council (HBMS IAC) Agency for Science, Technology and Research of Singapore.
  40. ↑ Global Leaders Group on Antimicrobial Resistance World Health Organization.
  41. ↑ Global Health Summit: Panel of Scientific Experts European Commission.
  42. ↑ SAGE Working Group on Dengue Vaccines and Vaccination (March 2015 to August 2016) World Health Organization.
  43. ↑ Julie Steenhuysen and Ben Hirschler (13 December 2017), Did Sanofi, WHO ignore warning signals on dengue vaccine? Reuters.
  44. ↑ R&D Blueprint Scientific Advisory Group members World Health Organization.
  45. ↑ WHO and World Bank Group Join Forces to Strengthen Global Health Security World Bank, press release of 24 May 2018.
  46. ↑ Global Preparedness Monitoring Board Announces New Board Membership, Bringing Diverse Expertise to Independent Monitoring World Bank/WHO Global Preparedness Monitoring Board (GPMB), press release of 30 September 2022.
  47. ↑ Donald G. McNeil Jr. (12 August 2019), A Cure for Ebola? Two New Treatments Prove Highly Effective in Congo The New York Times .
  48. ↑ Sarah Boseley (August 12, 2019), Ebola now curable after trials of drugs in DRC, say scientists The Guardian .
  49. 1 2 Funding and manufacturing boost for UK vaccine programme Government of the United Kingdom, press release of May 17, 2020.
  50. ↑ Mark Landler and Stephen Castle (April 23, 2020), The Secretive Group Guiding the U.K. on Coronavirus New York Times .
  51. ↑ List of participants of SAGE and related sub-groups, 7 May 2020 Government of the United Kingdom.
  52. ↑ Campbell, Denis (5 March 2023). "Matt Hancock plotted to oust NHS England chief, WhatsApp leak shows". the Guardian. Retrieved 5 March 2023.
  53. ↑ "Book review: Spike - The Virus vs the People, by Sir Jeremy Farrar and Anjana Ahuja | The Scotsman".
  54. ↑ Ducharme, Jamie (2 May 2024). "Jeremy Farrar". TIME. Retrieved 17 September 2024.
  55. ↑ UK’s progress on Covid now squandered, warns top scientist The Guardian
  56. ↑ Temasek Review 2019: Temasek International Panel Temasek Holdings.
  57. ↑ Climate & Health Initiative Planning Committee National Academy of Sciences (NAS).
  58. ↑ Who we are Geneva Science and Diplomacy Anticipator (GESDA).
  59. ↑ Appointments and changes to the Genome Research Limited Board Wellcome Trust Sanger Institute, press release of 9 December 2019.
  60. ↑ GHIT Fund Announces New Council Member Jeremy Farrar Global Health Innovative Technology Fund (GHIT Fund), press release of 8 August 2018.
  61. ↑ Clive Cookson (18 January 2017). "Davos launch for coalition to prevent epidemics of emerging viruses". Financial Times . Retrieved 6 March 2020. Billion-dollar programme aims to cut vaccine-development time from 12 years to one
  62. ↑ About Us Global He@lth 2030 Innovation Task Force.
  63. ↑ Strategic Advisory Board Global Alliance for Genomics and Health (GA4GH).
  64. ↑ Board of Trustess Aga Khan University.
  65. ↑ Advisory Board & Senior Sponsors Forward Institute.
  66. ↑ Governance Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
  67. ↑ Jeremy Farrar Francis Crick Institute.
  68. ↑ Office for Strategic Coordination of Health Research (OSCHR) National Health Service.
  69. ↑ Editors and Publishers The New England Journal of Medicine .
  70. ↑ International Advisory Board Patan Academy of Health Sciences (PAHS).
  71. ↑ Strategic Coherence of ODA-funded Research Archived 11 May 2020 at the Wayback Machine UK Collaborative on Development Research (UKCDR).
  72. ↑ Vanke School of Public Health: International Advisory Board Tsinghua University.
  73. ↑ Advisory Board WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases, University of Cambridge.
  74. ↑ Global Advisory Board WomenLift Health.
  75. ↑ "Global Leaders Group for antimicrobial resistance- Members". www.amrleaders.org. Archived from the original on 15 December 2021. Retrieved 17 January 2022.
  76. ↑ "No. 57509". The London Gazette (Supplement). 31 December 2004. p. 24.
  77. ↑ "Dr Jeremy Farrar OBE FMedSci". London: Academy of Medical Sciences. Archived from the original on 22 December 2015.
  78. ↑ "Professor Jeremy Farrar OBE FMedSci FRS". London: Royal Society. Archived from the original on 17 November 2015.
  79. ↑ "No. 62507". The London Gazette (Supplement). 29 December 2018. p. N2.
  80. ↑ "Farrar Foundation". farrarfoundation.org.
  81. ↑ Katrin Elger and Veronika Hackenbroch (8 December 2014), Epidemics Expert Jeremy Farrar: 'The Most Dangerous Emerging Disease Is Drug Resistance' Der Spiegel .
Cultural offices
Preceded by Director of the Wellcome Trust
2013 – date		Incumbent
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.